Skip to main content
OpenTrials
Completed

NCT Number: NCT01962077

Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth.

assess the effect of MedCem MTA as a pulp medicament following pulpotomy in human primary molars with carious pulp exposure in comparison to Formocresol.

Completed

Looking for future studies?

Notify Me

Key information

Age range

2 year–10 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hadassah Medical Organization

Jerusalem, 91120, Israel

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy children
  • with Asymptomatic primary molars with a deep carious lesion;
  • Exposure of a vital pulp by caries;
  • No clinical or radiographic evidence of pulp degeneration, such as excessive bleeding from the root canal, internal root resorption, inter-radicular and/or periapical bone destruction,swelling, or sinus tract;
  • Ability to perform a leakage free restoration of the teeth using stainless steel crown, or amalgam/resin based restoration.

Treatment and study plan

MedCem MTA pulpotomies in primary teeth.

Procedure

Primary outcomes

  1. Success of MedCem MTA pulpotomy in primary molar

    Time frame: Up to 36 months

    No pain, no swelling or sinus tract, no internal root resorption progressing into the bone, no furcation and/or periapical bond destruction.

Sponsors and collaborators

Lead sponsor

Hadassah Medical Organization

Other

Registry information

Official study title

Comparison of MedCem MTA and Formocresol Used in Pulpotomies in Primary Teeth

Important dates

Study start
2013
Primary completion
2021
Study completion
2021
First posted
Oct 14, 2013
Registry last updated
Jul 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.